Qianming Chen Selected Research

Oral Leukoplakia

9/2022	Laser-assisted photodynamic therapy in proliferative verrucous oral leukoplakia.
7/2021	Management of oral leukoplakia: a position paper of the Society of Oral Medicine, Chinese Stomatological Association.
1/2021	PD-1 blockade prevents the progression of oral carcinogenesis.
2/2019	Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
5/2011	Lycopene: features and potential significance in the oral cancer and precancerous lesions.
8/2009	Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis.
9/2008	ATM in oral carcinogenesis: association with clinicopathological features.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qianming Chen Research Topics

Disease

75	Neoplasms (Cancer) 08/2022 - 09/2002
45	Squamous Cell Carcinoma of Head and Neck 06/2022 - 12/2003
17	Oral Lichen Planus 01/2022 - 02/2008
12	Neoplasm Metastasis (Metastasis) 09/2022 - 12/2003
12	Carcinogenesis 01/2022 - 08/2003
10	Mouth Neoplasms (Oral Cancer) 07/2022 - 05/2011
8	Periodontitis 07/2022 - 07/2014
8	Inflammation (Inflammations) 01/2022 - 05/2013
7	Oral Leukoplakia 09/2022 - 09/2008
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017 - 03/2004
5	Infections 09/2022 - 05/2014
5	Bites and Stings (Sting) 01/2022 - 01/2018
5	Carcinoma (Carcinomatosis) 01/2020 - 06/2011
5	Head and Neck Neoplasms (Head and Neck Cancer) 06/2019 - 09/2014
5	Pain (Aches) 09/2017 - 10/2006
4	Uveal melanoma 01/2019 - 01/2013
4	Oral Submucous Fibrosis 09/2017 - 05/2011
3	Bacterial Infections (Bacterial Infection) 09/2022 - 05/2014
3	Adenoid Cystic Carcinoma (Cylindroma) 09/2022 - 10/2014
3	Hyperglycemia 08/2021 - 01/2021
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2015
3	Osteoarthritis 01/2019 - 06/2013
3	Chronic Periodontitis 01/2019 - 06/2013
3	Bone Resorption 01/2019 - 02/2012
3	Pemphigus (Pemphigus Vulgaris) 09/2016 - 04/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2018
2	Erythema 06/2022 - 10/2006
2	Ulcer 06/2022 - 05/2009
2	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2021
2	Hemorrhage 04/2022 - 09/2016
2	Wounds and Injuries (Trauma) 01/2022 - 01/2022
2	Oral Candidiasis (Thrush) 01/2022 - 03/2015
2	Pathologic Processes 10/2021 - 01/2019
2	Communicable Diseases (Infectious Diseases) 06/2021 - 04/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2017
2	COVID-19 10/2020 - 01/2020
2	Burning Mouth Syndrome (Syndrome, Burning Mouth) 08/2020 - 01/2007
2	Osteoporosis 01/2019 - 11/2018
2	Lymphatic Metastasis 10/2018 - 12/2003
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2017 - 01/2013

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 09/2022 - 08/2003
15	CytokinesIBA 01/2022 - 02/2008
14	Biomarkers (Surrogate Marker)IBA 09/2022 - 09/2008
12	Pharmaceutical PreparationsIBA 09/2022 - 02/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 05/2014
5	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2014
5	HydrogelsIBA 04/2022 - 01/2012
5	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2010
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2018
5	AntigensIBA 06/2018 - 05/2013
5	InterleukinsIBA 01/2016 - 04/2012
4	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2022 - 07/2015
4	Cadherins (E-Cadherin)IBA 09/2022 - 03/2004
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 11/2020
4	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2016
4	Interferon Type IIBA 01/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 02/2008
4	AntibodiesIBA 11/2021 - 10/2020
4	HMGN2 Protein (HMGN2)IBA 04/2018 - 01/2014
3	Circular RNAIBA 06/2022 - 01/2018
3	InflammasomesIBA 06/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2007
3	Receptors for Activated C KinaseIBA 01/2020 - 04/2012
3	GTP-Binding Proteins (G-Protein)IBA 01/2019 - 01/2013
3	MTOR InhibitorsIBA 01/2019 - 09/2014
3	Therapeutic UsesIBA 01/2018 - 01/2012
3	Messenger RNA (mRNA)IBA 01/2018 - 09/2008
3	Interleukin-10 (Interleukin 10)IBA 03/2017 - 07/2009
3	GlucocorticoidsIBA 09/2016 - 01/2014
3	Interleukin-23 (Interleukin 23)IBA 09/2015 - 06/2013
3	SaponinsIBA 01/2014 - 03/2013
3	amlexanox (Aphthasol)FDA Link 05/2012 - 10/2006
2	Photosensitizing Agents (Photosensitizers)IBA 09/2022 - 04/2022
2	Protein Kinases (Protein Kinase)IBA 09/2022 - 01/2021
2	ORALIT (ORS)IBA 07/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 12/2020
2	CollagenIBA 04/2022 - 01/2022
2	MethyltransferasesIBA 01/2022 - 11/2018
2	Monoclonal AntibodiesIBA 11/2021 - 06/2015
2	Biological ProductsIBA 10/2021 - 04/2010
2	NucleotidesIBA 01/2021 - 01/2013
2	ParaffinIBA 01/2021 - 10/2014
2	EnzymesIBA 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2017
2	Antiviral Agents (Antivirals)IBA 10/2020 - 09/2017
2	VaccinesIBA 10/2020 - 01/2018
2	Drug CarriersIBA 01/2020 - 01/2017
2	Immune Checkpoint InhibitorsIBA 12/2019 - 01/2018
2	LigandsIBA 01/2018 - 06/2015
2	Protein Isoforms (Isoforms)IBA 10/2017 - 06/2016
2	Cyclophilin AIBA 09/2017 - 09/2016
2	NucleosidesIBA 09/2017 - 10/2015

Therapy/Procedure

22	Therapeutics 09/2022 - 09/2008
9	Immunotherapy 01/2022 - 11/2017
5	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
4	Photochemotherapy (Photodynamic Therapy) 09/2022 - 11/2020
4	Oral Medicine 07/2021 - 03/2010
3	Radiotherapy 01/2022 - 01/2018
2	Lasers (Laser) 09/2022 - 02/2019
2	Biological Therapy 01/2019 - 05/2013